Alia Lalani, DPM
Foot & Ankle Surgery · Glendale, AZNPI 1598326779
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Stryker at 26.3% of the total. Reporting peaked in 2022 at $4,301 and has fallen 83.2% since, to $722 in 2025.
Across 52 payments — averaging $142.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Gemini Mountain Medical, LLC$1K
- Impactortho, Inc.$1K
- Treace Medical Concepts, Inc.$1K
- Paragon 28, Inc.$621
- Amgen$417
- plus $873 from 8 others
What the payments were for
- Travel & lodging$1,94826%
- Food & beverage$3,06541%
- Education$2,40032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $1,952 |
| Gemini Mountain Medical, LLC | 1 | $1,200 |
| Impactortho, Inc. | 1 | $1,200 |
| Treace Medical Concepts, Inc. | 8 | $1,151 |
| Paragon 28, Inc. | 3 | $621 |
| Amgen(2 entities) | 7 | $417 |
| Biowound Solutions, Inc. | 2 | $271 |
| Orthofix Medical, Inc. | 6 | $187 |
| Abbott | 1 | $152 |
| DJO, LLC | 3 | $99 |
| Johnson & Johnson | 1 | $73 |
| Medtronic | 2 | $41 |
| Mimedx Group, Inc. | 1 | $37 |
| Trice Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$972
- PROstep$952
- MONKEY RINGS$535
- KRYSTEXXA$343
- bio-ConneKt$271
- ORTHOLOC 2 LAPIFUSE$175
- PROCLAIM$152
- N/A$128
- ORTHOLOC 3DI$124
- VARIAX$123
How this compares
$7,413 in reported general payments places this provider in the 75th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 61 | $1,141 |
| Fluconazole | 24 | $648 |
| Doxycycline Monohydrate | 30 | $566 |
| Cephalexin | 38 | $263 |
| Ondansetron OdtOndansetron | 12 | $224 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $117 |
| Meloxicam | 39 | $75 |
| Clindamycin Hcl | 16 | $60 |
| Tramadol Hcl | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Glendale
- Jessica RandolphGlendale$40K
- Dustin DoyleGlendale$18K
- Johanna Marie RicheyGlendale$10K
- Ryan ScottPhoenix$1.1M
- Jeffrey McAlisterScottsdale$578K
- Jeffrey HolmesPhoenix$509K
- Myron HansenChandler$480K
- Scott MalingMesa$382K
- Melissa GalliPhoenix$324K
- Geoffrey LandisTucson$307K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.